Mycronic publ AB (MYCR)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 303.00 |
|---|---|
| 52-week range | 183.32 – 364.40 |
| Return, 1 month / 3 months | −9.3% / −8.8% |
| Return, 1 year / 3 years | +39.1% / +163.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 40 |
| Volatility (1 year) | 38.7% |
| Worst drawdown (1 year) | -18.2% |
| Average daily value traded | 83.04M SEK |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mycronic is a Swedish industrial technology company that builds production equipment for electronics manufacturing. Its product lines include surface-mount technology assembly machines, dispensing and jetting systems for electronics production, and mask writers used to make photomasks for displays and semiconductors. Customers are manufacturers in the electronics, display and semiconductor industries, who use the equipment in their production lines. The company is based in Taby, Sweden, and serves customers in markets around the world.
The shares are listed on the Nasdaq Stockholm in Sweden under the code MYCR, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mycronic publ AB (MYCR) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 303.00 on 27 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 137 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 39.1% and over the last three months it fell 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.5% | ||
| From 52-week high | -15.6% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -8.8% | ||
| 6-month return | 4.6% | ||
| 12-month return, skipping the last month | 53.4% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 38.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.2% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 83.04M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.9% |
|---|---|
| 1 month | −9.3% |
| 3 months | −8.8% |
| 6 months | +4.6% |
| 1 year | +39.1% |
| 3 years | +163.7% |
| 5 years | +222.0% |
Signals
| 50-day / 200-day average | 322.92 / 279.18 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | SEK 3.2500 |
| 8 May 2025 | SEK 5.5000 |
| 10 May 2024 | SEK 4.5000 |
| 10 May 2023 | SEK 3.5000 |
| 6 May 2022 | SEK 3.0000 |
| 6 May 2021 | SEK 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.